SELENIUM: A NOUVELLE APPROACH FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS

• In: Poster Session
• At: Düsseldorf (Germany) (2015)
• Type: Poster
• By: FARRAG, Nada (Misr International University, Clinical Pharmacy and Pharmacy Practice, Cairo, Egypt)
• Co-author(s): Nada Hazem Mohammed
  
• Abstract:

  Idiopathic pulmonary fibrosis (IPF), the common aggressive form of the interstitial pneumonias. It is chronic, progressive, irreversible and lethal lung disease with a poor prognosis. 

  The current study is a prospective, randomized comparative study. Eligible patients were randomly assigned to either group A; 20 patients received oral Selenium 200 µ

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login